Human Placenta Expresses and Secretes NKG2D Ligands via Exosomes that Down-Modulate the Cognate Receptor Expression: Evidence for Immunosuppressive Function
- 1 July 2009
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 183 (1), 340-351
- https://doi.org/10.4049/jimmunol.0803477
Abstract
During mammalian pregnancy maternal-fetal tolerance involves a number of immunosuppressive factors produced by placenta. Recently, placenta-derived exosomes have emerged as new immune regulators in the maternal immune tolerance. Exosomes are membrane nanovesicles with defined morphology, which are secreted from endosomal multivesicular bodies (MVB) upon fusion with the plasma membrane. Previously, we reported that the MHC class I chain-related (MIC) proteins A and B, human ligands of the activating NK cell receptor NKG2D, are expressed by placenta, sorted to MVB of syncytiotrophoblast and probably released via MIC-bearing exosomes. In this report, we show that the second family of human NKG2D ligands, the UL-16 binding proteins (ULBP), is also expressed by placenta. Importantly, this expression was not due to placental CMV infection. Immunoelectron microscopy disclosed that ULBP1-5 are produced and retained in MVB of the syncytiotrophoblast on microvesicles/exosomes. Using human placenta explant cultures and different assays, we demonstrate that exosomes bearing NKG2D ligands are released by human placenta. Isolated placental exosomes carried ULBP1-5 and MIC on their surface and induced down-regulation of the NKG2D receptor on NK, CD8(+), and gammadelta T cells, leading to reduction of their in vitro cytotoxicity without affecting the perforin-mediated lytic pathway. Release of placental NKG2D ligands via exosomes is an alternative mechanism for generation of bioactive soluble form of these ligands. These findings highlight a role for NKG2D ligand-bearing placental exosomes in the fetal immune escape and support the view of placenta as a unique immunosuppressive organ.Keywords
This publication has 54 references indexed in Scilit:
- Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules, HLA-F and CD48Human Reproduction, 2008
- ORIGINAL ARTICLE: An Efficient Optimized Method for Isolation of Villous Trophoblast Cells from Human Early Pregnancy Placenta Suitable for Functional and Molecular StudiesAmerican Journal of Reproductive Immunology, 2008
- REVIEW ARTICLE: Evolution of Non‐Cytotoxic Uterine Natural Killer CellsAmerican Journal of Reproductive Immunology, 2008
- Cancer Immunosurveillance: NKG2D Breaks CoverImmunity, 2008
- Inflammation, Cancer and Chemoresistance: Taking Advantage of the Toll‐Like Receptor Signaling PathwayAmerican Journal of Reproductive Immunology, 2007
- Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblastsHuman Reproduction Update, 2006
- NKG2D-mediated activation of cytotoxic lymphocytes: Unique signaling pathways and distinct functional outcomesSeminars in Immunology, 2006
- The DNA damage pathway regulates innate immune system ligands of the NKG2D receptorNature, 2005
- Multivesicular bodies: a mechanism to package lytic and storage functions in one organelle?Trends in Cell Biology, 2002
- "Tolerosomes" are produced by intestinal epithelial cellsEuropean Journal of Immunology, 2001